{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T21:26:25Z","timestamp":1748985985763},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,5]]},"DOI":"10.4103\/0366-6999.239315","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T13:38:23Z","timestamp":1534513103000},"page":"2105-2111","source":"Crossref","is-referenced-by-count":3,"title":["Peripheral T-cell Lymphomas"],"prefix":"10.1097","volume":"131","author":[{"given":"Wen-Rong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai-Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","article-title":"Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States","volume":"34","author":"Adams","year":"2016","journal-title":"J Clin Oncol"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-6-77","article-title":"Subtype distribution of lymphomas in southwest china: Analysis of 6,382 cases using WHO classification in a single institution","volume":"6","author":"Yang","year":"2011","journal-title":"Diagn Pathol"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: A report of 340 cases from the international peripheral T-cell lymphoma project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2014-04-573089","article-title":"Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: A study from the Swedish lymphoma registry","volume":"124","author":"Ellin","year":"2014","journal-title":"Blood"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hon.2396","article-title":"The role of stem cell transplant for lymphoma in 2017","volume":"35","author":"Gribben","year":"2017","journal-title":"Hematol Oncol"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d\u2019Amore","year":"2012","journal-title":"J Clin Oncol"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/annonc\/mdx787","article-title":"Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: An analysis of patients from LYSA centers","volume":"29","author":"Fossard","year":"2018","journal-title":"Ann Oncol"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000353778","article-title":"Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: Results of a comprehensive meta-analysis","volume":"131","author":"Yin","year":"2014","journal-title":"Acta Haematol"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1080\/10428194.2017.1312379","article-title":"Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: A subset analysis of the Canadian cancer trials group LY.12 randomized phase 3 study","volume":"58","author":"Skamene","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2011.240","article-title":"Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed\/refractory peripheral T-cell lymphomas: Long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect","volume":"26","author":"Dodero","year":"2012","journal-title":"Leukemia"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/bmt.2014.243","article-title":"Graft-versus-T-cell lymphoma effect: A sustained CR after tapering immunosuppressive drugs in a patient with angioimmunoblastic T-cell lymphoma in relapse after allogeneic transplantation","volume":"50","author":"Mamez","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2006.06004.x","article-title":"Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents \u2013 A Berlin-Frankfurt-M\u00fcnster group report","volume":"133","author":"Woessmann","year":"2006","journal-title":"Br J Haematol"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1200\/JCO.2008.20.4628","article-title":"Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: A retrospective study from the lymphoma working party of the European group for blood and marrow transplantation","volume":"27","author":"Kyriakou","year":"2009","journal-title":"J Clin Oncol"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3109\/10428194.2011.572322","article-title":"Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer\/T-cell lymphoma, nasal type","volume":"52","author":"Ennishi","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbmt.2008.01.002","article-title":"Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect","volume":"14","author":"Hamadani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2014.79","article-title":"Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma","volume":"28","author":"Corradini","year":"2014","journal-title":"Leukemia"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/annonc\/mdu515","article-title":"Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: An intention-to-treat analysis from a single center","volume":"26","author":"Loirat","year":"2015","journal-title":"Ann Oncol"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1200\/JCO.2012.46.0188","article-title":"Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma","volume":"31","author":"Smith","year":"2013","journal-title":"J Clin Oncol"},{"key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/leu.2012.321","article-title":"Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology","volume":"27","author":"Kim","year":"2013","journal-title":"Leukemia"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: Long-term treatment outcome and relationship with the international prognostic index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12185-010-0726-2","article-title":"Treatment of advanced extranodal NK\/T cell lymphoma, nasal-type and aggressive NK-cell leukemia","volume":"92","author":"Suzuki","year":"2010","journal-title":"Int J Hematol"},{"key":"R22-12-20210129","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/annonc\/mdq698","article-title":"A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides\/Sezary syndrome","volume":"22","author":"Jacobsen","year":"2011","journal-title":"Ann Oncol"},{"key":"R23-12-20210129","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1182\/blood-2004-01-0231","article-title":"Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: A report of the international bone marrow transplant registry","volume":"104","author":"Freytes","year":"2004","journal-title":"Blood"},{"key":"R24-12-20210129","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/blood-2005-02-0596","article-title":"Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: A nationwide survey in Japan","volume":"108","author":"Kim","year":"2006","journal-title":"Blood"},{"key":"R25-12-20210129","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bbmt.2011.12.581","article-title":"Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure","volume":"18","author":"Freytes","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","article-title":"Survival of patients with peripheral T-cell lymphoma after first relapse or progression: Spectrum of disease and rare long-term survivors","volume":"31","author":"Mak","year":"2013","journal-title":"J Clin Oncol"},{"key":"R27-12-20210129","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: Working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","article-title":"Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells","volume":"22","author":"Corradini","year":"2004","journal-title":"J Clin Oncol"},{"key":"R29-12-20210129","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/CCO.0b013e32834bb88e","article-title":"Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma","volume":"23","author":"van Besien","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"R30-12-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bmt.1703790","article-title":"Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma","volume":"31","author":"Kiss","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R31-12-20210129","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbmt.2013.01.006","article-title":"Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma","volume":"19","author":"Kanakry","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R32-12-20210129","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbmt.2008.01.008","article-title":"Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: Importance of histology for outcome","volume":"14","author":"Armand","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R33-12-20210129","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JCO.2008.17.3328","article-title":"Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma","volume":"27","author":"Thomson","year":"2009","journal-title":"J Clin Oncol"},{"key":"R34-12-20210129","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.bbmt.2011.02.009","article-title":"Relapse of lymphoma after allogeneic hematopoietic cell transplantation: Management strategies and outcome","volume":"17","author":"Wudhikarn","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R35-12-20210129","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/bmt.2015.12","article-title":"Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT lymphoma working party","volume":"50","author":"Horstmann","year":"2015","journal-title":"Bone Marrow Transplant"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.239315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:48:55Z","timestamp":1623959335000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201809050-00012"}},"subtitle":["Updates in Allogeneic Hematopoietic Stem Cell Transplantation"],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":35,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.239315","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,5]]}}}